Kumar, S. K., Dispenzieri, A., Lacy, M. Q., Hayman, S. R., Buadi, F. K., Zeldenrust, S. R., . . . Gertz, M. A. (2011). Changes in serum-free light chain rather than intact monoclonal immunoglobulin levels predicts outcome following therapy in primary amyloidosis.
Čikaški stil citiranjaKumar, Shaji K., et al. Changes in Serum-free Light Chain Rather Than Intact Monoclonal Immunoglobulin Levels Predicts Outcome Following Therapy in Primary Amyloidosis. 2011.
MLA način citiranjaKumar, Shaji K., et al. Changes in Serum-free Light Chain Rather Than Intact Monoclonal Immunoglobulin Levels Predicts Outcome Following Therapy in Primary Amyloidosis. 2011.
Upozorenje: Ovi citati možda nisu uvijek 100% točni.